Workflow
Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race
诺和诺德诺和诺德(US:NVO) Reuters·2025-11-14 07:19

公司人事变动 - 诺和诺德宣布辉瑞前研发主管Mikael Dolsten因个人原因退出其董事会候选人提名 [1]